Agile Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.44
|
-0.53
|
-0.09
|
-20.45%
|
|
2022-06-30
|
-3.70
|
-2.71
|
0.99
|
26.76%
|
|
2022-03-31
|
-6.00
|
-3.78
|
2.22
|
37.00%
|
|
2021-12-31
|
-6.00
|
-8.00
|
-2.00
|
-33.33%
|
|
2021-09-30
|
-7.70
|
-7.20
|
0.50
|
6.49%
|
|
2021-06-30
|
-8.64
|
-8.00
|
0.64
|
7.41%
|
|
2021-03-31
|
-8.56
|
-8.00
|
0.56
|
6.54%
|
|
2020-12-31
|
-8.96
|
-8.00
|
0.96
|
10.71%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.02
|
|
2021-12-31
|
-31.20
|
|
2020-12-31
|
-24.00
|
|
2019-12-31
|
-0.39
|
|
2018-12-31
|
-0.58
|
|
2017-12-31
|
-0.92
|
|
2016-12-31
|
-1.12
|
|
2015-12-31
|
-1.64
|
|
2014-12-31
|
-0.96
|